No company description available.
Join Vor in tackling autoimmune disease at its root by advancing telitacicept, a dual BAFF/APRIL inhibitor. As a Medical Science Liaison (MSL) in Rheumatology, you will foster partnerships with healthcare professionals and support clinical trial execution. The primary focus will be advancing the development of telitacicept for Sjogren’s Disease.
Vor Bio